Engineering groups at Rutgers and MIT constructed solid-dosage continuous manufacturing lines and transferred the technology to pharmaceutical industry partners. ...
News & Press
Several drugmakers have been flirting with continuous process manufacturing, but none have fully engaged with the idea. GlaxoSmithKline has been working on the new technology for 5 or 6 years and is now ready to make a serious commitment to a method that requires radically smaller plants and,...
On November 13, 2012, the Novartis-MIT Center for Continuous Manufacturing hosted a symposium with industry leaders on continuous manufacturing of pharmaceuticals. ...
In the run up to the Developability of Biopharmaceuticals...
On October 15, 2012, the Wall Street Journal named the Novartis-MIT Center for Continuous Manufacturing a runner-up in the Manufacturing Technology category in this year's Wall Street Journal Technology Innovation Awards. The WSJ received 536 entries, with only 7% receiving an...